Zydus Lifesciences bags USFDA okay for Ketoconazole shampoo for dandruff
Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Ketoconazole Shampoo, 2% (USRLD: Nizoral Shampoo, 2%).
Ketoconazole shampoo is an antifungal medication used to treat dandruff, fungal infections, and other skin conditions.
Ketoconazole shampoo will be produced at the Group’s topical manufacturing site at Changodar, Ahmedabad. Ketoconazole shampoo had annual sales of USD 68.89 mn in the United States (IQVIA MAT January 2025). The group now has 418 approvals and has so far filed 483* ANDAs since the commencement of the filing process in FY 2003-04.
Read also: USFDA nod to Zydus Lifesciences cancer drug Dasatinib
Zydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Read also: CDSCO Panel approves Zydus Lifesciences to study Semaglutide Injection
